The role of intra-vascular imaging in patients undergoing intravascular lithotripsy: Insights from the COIL registry.

Intra‐vascular lithotripsy intra‐coronary imaging in‐stent restenosis stent failure

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
15 Sep 2024
Historique:
revised: 07 08 2024
received: 10 05 2024
accepted: 04 09 2024
medline: 16 9 2024
pubmed: 16 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

The role of intra-coronary imaging in patients with stent failure undergoing intravascular lithotripsy (IVL) is unclear. We aimed to assess clinical outcomes in patients undergoing IVL treatment for stent failure stratified according to the use of intra-coronary imaging and lesion complexity. This is a pre-specified subgroup analysis of patients who were included in the coronary intravascular lithotripsy in patients with stent failure (COIL) registry (international multi-centre study assessing IVL treatment for stent failure in 6 European centres). A complex lesion was defined if IVL treatment was used in the left main, true bifurcation, long lesion, or coupled with athero-ablative therapy. The primary endpoint was the composite of cardiac death, spontaneous myocardial infarction, or target vessel revascularization (TVR) at 12 months. There were 102 patients analyzed, of whom 27 (26%) patients had complex anatomy. The use of intra-coronary imaging following IVL in stent failure was more frequent in patients with complex versus Noncomplex anatomy (56% vs. 31%, p = 0.022). IVL treatment was effective in both groups, however, patients with complex anatomy had worse clinical outcomes (30% vs. 11%, p = 0.02), driven by a higher rate of TVR (26% vs. 8%, p = 0.017). In the complex group, patients who underwent intracoronary imaging post intervention had lower event rate compared to those without imaging (13% vs. 50%, p = 0.038). In patients undergoing IVL treatment for stent failure with complex coronary anatomy, the use of intra-coronary imaging was associated with fewer adverse events compared to angiography guided intervention.

Sections du résumé

BACKGROUND BACKGROUND
The role of intra-coronary imaging in patients with stent failure undergoing intravascular lithotripsy (IVL) is unclear. We aimed to assess clinical outcomes in patients undergoing IVL treatment for stent failure stratified according to the use of intra-coronary imaging and lesion complexity.
METHODS METHODS
This is a pre-specified subgroup analysis of patients who were included in the coronary intravascular lithotripsy in patients with stent failure (COIL) registry (international multi-centre study assessing IVL treatment for stent failure in 6 European centres). A complex lesion was defined if IVL treatment was used in the left main, true bifurcation, long lesion, or coupled with athero-ablative therapy. The primary endpoint was the composite of cardiac death, spontaneous myocardial infarction, or target vessel revascularization (TVR) at 12 months.
RESULTS RESULTS
There were 102 patients analyzed, of whom 27 (26%) patients had complex anatomy. The use of intra-coronary imaging following IVL in stent failure was more frequent in patients with complex versus Noncomplex anatomy (56% vs. 31%, p = 0.022). IVL treatment was effective in both groups, however, patients with complex anatomy had worse clinical outcomes (30% vs. 11%, p = 0.02), driven by a higher rate of TVR (26% vs. 8%, p = 0.017). In the complex group, patients who underwent intracoronary imaging post intervention had lower event rate compared to those without imaging (13% vs. 50%, p = 0.038).
CONCLUSIONS CONCLUSIONS
In patients undergoing IVL treatment for stent failure with complex coronary anatomy, the use of intra-coronary imaging was associated with fewer adverse events compared to angiography guided intervention.

Identifiants

pubmed: 39279142
doi: 10.1002/ccd.31227
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Giustino G, Colombo A, Camaj A, et al. Coronary In‐Stent restenosis. J Am Coll Cardiol. 2022;80:348‐372.
Moussa ID, Mohananey D, Saucedo J, et al. Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol. 2020;76:1521‐1531.
Scafa‐Udriște A, Itu L, Puiu A, Stoian A, Moldovan H, Popa‐Fotea NM. In‐stent restenosis in acute coronary syndrome‐a classic and a machine learning approach. Front Cardiovasc Med. 2023;10:1270986.
Elbadawi A, Dang AT, Mahana I, et al. Outcomes of percutaneous coronary intervention for In‐Stent restenosis versus de novo lesions: A meta‐analysis. J Am Heart Assoc. 2023;12:e029300.
Buccheri D, Piraino D, Andolina G, Cortese B. Understanding and managing in‐stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8:E1150‐E1162.
Shlofmitz E, Iantorno M, Waksman R. Restenosis of Drug‐Eluting stents: A new classification system based on disease mechanism to guide treatment and State‐of‐the‐Art review. Circ Cardiovasc Interv. 2019;12:e007023.
Zaidan M, Alkhalil M, Alaswad K. Calcium modification therapies in contemporary percutaneous coronary intervention. Curr Cardiol Rev. 2022;18:e281221199533.
Wanha W, Tomaniak M, Wanczura P, et al. Intravascular lithotripsy for the treatment of stent underexpansion: the multicenter IVL‐DRAGON registry. J Clin Med. 2022;11(7):1779. doi:10.3390/jcm11071779
Kuzemczak M, Lipiecki J, Jeyalan V, et al. Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry). Int J Cardiol. 2023;391:131274.
Choi JM, Choi KH, Song YB, et al. InvestigatorsR‐C‐P. intravascular imaging‐guided or angiography‐guided complex PCI. N Engl J Med. 2023;388:1668‐1679.
Holm NR, Andreasen LN, Neghabat O, et al. OCT or angiography guidance for PCI in complex bifurcation lesions. N Engl J Med. 2023;389:1477‐1487.
Stone GW, Christiansen EH, Ali ZA, et al. Intravascular imaging‐guided coronary drug‐eluting stent implantation: an updated network meta‐analysis. Lancet. 2024;403:824‐837.
Mentias A, Sarrazin MV, Saad M, et al. Long‐Term outcomes of coronary stenting with and without use of intravascular ultrasound. Cardiovasc Interv. 2020;13:1880‐1890.
Erdogan E, Bajaj R, Lansky A, Mathur A, Baumbach A, Bourantas CV. Intravascular imaging for guiding In‐Stent restenosis and stent thrombosis therapy. J Am Heart Assoc. 2022;11:e026492.
Pal N, Din J, O'Kane P. Contemporary management of stent failure: part one. Interv Cardiol Rev. 2019;14:10‐16.
Hill JM, Kereiakes DJ, Shlofmitz RA, et al. Intravascular lithotripsy for treatment of severely calcified coronary Artery disease. J Am Coll Cardiol. 2020;76:2635‐2646.
Ali ZA, Nef H, Escaned J, et al. Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the disrupt CAD II study. Circ Cardiovasc Interv. 2019;12:e008434.
Tovar Forero MN, Sardella G, Salvi N, et al. Coronary lithotripsy for the treatment of underexpanded stents: the international & multicentre CRUNCH registry. EuroIntervention. 2022;18:574‐581.
Choi SY, Witzenbichler B, Maehara A, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS‐AMI) substudy. Circ Cardiovasc Interv. 2011;4:239‐247.
Song HG, Kang SJ, Ahn JM, et al. Intravascular ultrasound assessment of optimal stent area to prevent in‐stent restenosis after zotarolimus‐, everolimus‐, and sirolimus‐eluting stent implantation. Catheter Cardiovasc Interv. 2014;83:873‐878.
Honton B, Lipiecki J, Monségu J, et al. Mid‐term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: insights from the French shock initiative. Int J Cardiol. 2022;365:106‐111.
Brunner F, Becher P, Waldeyer C, et al. Intravascular lithotripsy for the treatment of Calcium‐Mediated coronary In‐Stent restenoses. J Invasive Cardiol. 2021;33:E25‐E31.
Kassab K, Kassier A, Fischell TA. Intracoronary lithotripsy use for In‐Stent restenosis, including multilayer ISR. Cardiovasc Revasc Med. 2022;44:10‐13.
Farhat H, Kuzemczak M, Durel N, Caillot N, Pawłowski T, Lipiecki J. Rotational atherectomy versus intravascular lithotripsy for calcified In‐Stent restenosis: A Single‐Center study with 1‐Year Follow‐Up. Am J Cardiol. 2023;205:413‐419.
Protty M, Sharp ASP, Gallagher S, et al. Defining percutaneous coronary intervention complexity and risk. Cardiovasc Interv. 2022;15:39‐49.
Kim JH, Kang DY, Ahn JM, et al. Optimal minimal stent area and impact of stent underexpansion in left main Up‐Front 2‐Stent strategy. Circ Cardiovasc Interv. 2024;17:e013006.
Romagnoli E, Ramazzotti V, Burzotta F, et al. Definition of optimal optical coherence Tomography‐Based stent expansion criteria: In‐Stent minimum lumen area versus residual stent underexpansion. Circ Cardiovasc Interv. 2022;15:e011496.
Giacoppo D, Alfonso F, Xu B, et al. Paclitaxel‐coated balloon angioplasty vs. drug‐eluting stenting for the treatment of coronary in‐stent restenosis: a comprehensive, collaborative, individual patient data meta‐analysis of 10 randomized clinical trials (DAEDALUS study). Eur Heart J. 2020;41:3715‐3728.
Park KW, Kang SH, Yang HM, et al. Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial. Int J Cardiol. 2013;167:721‐726.
Ali ZA, Landmesser U, Maehara A, et al. Optical coherence Tomography–Guided versus Angiography‐Guided PCI. N Engl J Med. 2023;389:1466‐1476.

Auteurs

Bilal Bawamia (B)

Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK.

Michał Kuzemczak (M)

Department of Cardiology, Medical University of Lodz, Biegański Hospital, Łódź, Poland.
Division of Emergency Medicine, University of Medical Sciences, Poznan, Poland.
Department of Interventional Cardiology and Internal Medicine, Military Institute of Medicine - National Research Institute, Legionowo, Poland.

Janusz Lipiecki (J)

Centre de Cardiologie Interventionnelle, Pôle Santé République, Clermont-Ferrand, France.

Jacek Legutko (J)

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Clinical Department of Interventional Cardiology, John Paul II Hospital, Cracow, Poland.

Johan Bennett (J)

Department of Cardiovascular Medicine, KU Leuven, University Hospitals Leuven, Leuven, Belgium.

Joseph Dens (J)

Ziekenhuis Oost-Limburg, Genk, Belgium.

Mohammad Alkhalil (M)

Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK.
Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.

Classifications MeSH